While Glucotrol is generally well-tolerated, some patients may experience mild to moderate side effects as their bodies adjust to the medication: Though rare, more serious side effects require immediate medical attention: Patients using Glucotrol should remain vigilant for signs of side effects, particularly hypoglycemia, due to its potentially severe consequences
Nonetheless, several groups should be considered at elevated risk and would generally be advised against use outside a controlled clinical trial
Int J Epidemiol 2017;46:799-800.PubMed 17
Targeting Metabolic Dysfunction in Parkinsons Disease: The Role of GLP-1 Agonists in Body Weight Regulation and Neuroprotection
Free healthcare enhances generalizability, and unique personal identifiers enabled complete linkage across registers, providing full follow-up on suicide and suicide attempts from mortality and hospital data
In January 2023, Pirtobrutinib (Jaypirca) was approved in the USA for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL) [1]